Scholars Central

Mini reviewPublished 28 Jul 2023

Revolutionizing Biopharm Manufacturing: The Future of Bioprocessing

Authors: Lisa Bero

Pharmaceutical Bioprocessing

Volume 11 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bioprocessing in the pharmaceutical industry refers to the use of biological systems, such as living cells or enzymes, to produce therapeutic drugs and other valuable products. This innovative approach harnesses the power of biological agents to manufacture complex molecules, like proteins and antibodies that are difficult or impossible to synthesize through traditional chemical methods. The process involves various stages, starting with cell cultivation in bioreactors, where nutrients and environmental conditions are carefully controlled to promote cell growth and product formation. Once the cells have produced the desired compounds, downstream processing steps, including purification and formulation, are employed to isolate and refine the target molecule.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Bioprocessing.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Bioprocessing
  • SubjectPharmaceutical Sciences
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Lisa Bero”